Search results for "Cytiva" in Articles / App Notes

Article A scalable single-use two-step plasmid purification process
The current global demand for biopharmaceuticals is over USD 300 billion, with an estimated growth of ≥ 12% annually. While MAb processes have become much more efficient, production of mRN…

Article Exploring the world of antibodies: mAbs, Fabs, dAbs, and bsAbs
There is a vast array of antibody variants, including multispecific (msAb), bispecific antibodies (bsAb), antibody fragments (Fab, dAb, scFv), and antibody-drug conjugates (ADC). But with this…

Article How to put mechanistic modeling into practice
Make it happen! Learn about insider recommendations to get started with in silico process development. Check out our resources on good modeling practice, case studies, and other publication…

Article Interactive eBook - Understand and unlock the potential of digital scaling
Ready for smarter scaling? Explore the possibilities with a digital process to reduce time and costs associated with your operations. Get started by downloading our free eBook. DOWNLOAD EBO…

Article Democratizing GMP Manufacturing for the New Therapeutic Pipeline
PharmTech Europe discusses technology that enables the “democratization” of mRNA manufacturing with Scott Ripley, general manager, Nucleic Acid Therapeutics and Precision Nanosystems, Cytiva, …

Article Getting your investigational drug regulatory ready
Navigating regulatory requirements can be an overwhelming and time-consuming part of the translational journey. From the submission of an investigational new drug (IND) application, regulators…

Article Insights from process developers - top challenges in recombinant protein purification
You might be one of the many process developers who are working on a diversity of molecules such as enzymes, peptides, scaffolds, and other recombinant proteins. This constantly evolving molecul…

Article Good modeling practice: workflow and case study
Learn more about a recommended mechanistic modeling workflow for successful in silico chromatography process development. The workflow is illustrated with examples from a modeling case study a…

Article Developing oligonucleotide therapeutics with confidence
In this video, we will look at key considerations for oligo therapeutic developers entering the market, such as scalability, flexibility, regulatory concerns, insource/outsource consideratio…

Article Chromatography processes for the diversified therapeutic antibody pipeline
The diversity of antibody variants in today’s pipeline presents unique challenges for purification and we see molecules such as bsAbs, Fabs, dAbs, and others. Conventional chromatography protocols, …

Show All Results

Previous PageNext Page